Clinical Trial Update: Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy

View source ↗

Summary

This clinical trial update reports on analysis of HIV genetic variation in patients before starting highly active antiretroviral therapy (HAART).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection | Status: COMPLETED